|
|
||||||||
-synuclein aggregates in autonomic plexuses predate Lewy body disorders?From the Departments of Neurology (A.M.-C., F.E.-S., A.O.-M.), Pathology and Tumor and Tissue Bank (C.E.C., A.C.), and Nuclear Medicine (A.C.R., M.G.-R.), Virgen de las Nieves University Hospital, Granada, and Tissue Bank for Neurological Research (D.G.M.), Madrid, Spain; and St. Michael's Hospital (D.G.M.), University of Toronto, Ontario, Canada.
Address correspondence and reprint requests to Dr. A. Mínguez-Castellanos, Servicio de Neurología, Hospital Universitario Virgen de las Nieves, CRT 3ª planta, Carretera de Jaén s/n, 18013 Granada, Spain aminguezc{at}meditex.es
Objective: To determine the prevalence of
-synuclein (AS) aggregates in abdominopelvic autonomic plexuses in the general population and to evaluate the relationship between this finding and the subsequent development of neurologic dysfunction.
Methods: First, surgical specimens from 100 patients (ages 44 to 84) undergoing a wide resection of an abdominopelvic organ were examined by anti-AS immunostaining. Second, 16 patients (6 AS+ and 10 randomly selected AS) participated in yearly double-blinded neurologic assessments.
Results: AS aggregates were found in autonomic plexuses in 9% of the whole sample (95% CI 3.4 to 14.6%) but were more common in vesicoprostatic (26%) than in digestive tract (4%) specimens. At 16 months after the biopsy, no prevalent cases of Parkinson disease, dementia, or autonomic failure were diagnosed among participants. One AS+ patient had previously been diagnosed with REM sleep behavior disorder. Seven of 10 control subjects but none of the 6 AS+ patients had a diagnosis of hypertension (p = 0.01). During phase IV of Valsalva maneuver, AS+ group exhibited a longer blood pressure recovery time (p = 0.03), with one patient showing absence of blood pressure overshoot. Cardiac [123I]metaiodobenzylguanidine uptake was reduced in the AS+ group (p = 0.03). Striatal [123I]ioflupane uptake was abnormally low in only one AS+ patient. At 30 months after the biopsy, lower cardiac and striatal uptake values tended to correlate with higher Unified Parkinson's Disease Rating Scale III scores (p = 0.07).
Conclusion: The common presence of
-synuclein aggregates in peripheral autonomic neurons may represent an early presymptomatic phase in the development of Lewy body disorders.
*These authors contributed equally to this work.
Supported by grants from "Fundacion Virgen de las Nieves," "Consejeria de Salud" of the Andalusian Government (189/02), and "Instituto Carlos III" of the Spanish Government (FIS 0310/03; Red CIEN C03/06).
Disclosure: The authors report no conflicts of interest.
Received May 31, 2006. Accepted in final form February 5, 2007.
This article has been cited by other articles:
![]() |
R. Savica, J. M. Carlin, B. R. Grossardt, J. H. Bower, J. E. Ahlskog, D. M. Maraganore, A. E. Bharucha, and W. A. Rocca Medical records documentation of constipation preceding Parkinson disease: A case-control study Neurology, November 24, 2009; 73(21): 1752 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Isaacson and R. A. Hauser Review: Improving symptom control in early Parkinson's disease Therapeutic Advances in Neurological Disorders, November 1, 2009; 2(6): 393 - 400. [Abstract] [PDF] |
||||
![]() |
C. W. Olanow and S. B. Prusiner Is Parkinson's disease a prion disorder? PNAS, August 4, 2009; 106(31): 12571 - 12572. [Full Text] [PDF] |
||||
![]() |
Y. Akaogi, M. Asahina, Y. Yamanaka, Y. Koyama, and T. Hattori Sudomotor, skin vasomotor, and cardiovascular reflexes in 3 clinical forms of Lewy body disease Neurology, July 7, 2009; 73(1): 59 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Olanow, M. B. Stern, and K. Sethi The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology, May 26, 2009; 72(21_Supplement_4): S1 - S136. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Silveira-Moriyama, C. Mathias, L. Mason, C. Best, N. P. Quinn, and A. J. Lees Hyposmia in pure autonomic failure Neurology, May 12, 2009; 72(19): 1677 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tolosa, C. Gaig, J. Santamaria, and Y. Compta Diagnosis and the premotor phase of Parkinson disease Neurology, February 17, 2009; 72(7_Supplement_2): S12 - S20. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mena and J. Garcia de Yebenes Glial Cells as Players in Parkinsonism: The "Good," the "Bad," and the "Mysterious" Glia Neuroscientist, December 1, 2008; 14(6): 544 - 560. [Abstract] [PDF] |
||||
![]() |
H. Braak and K. Del Tredici Invited Article: Nervous system pathology in sporadic Parkinson disease Neurology, May 13, 2008; 70(20): 1916 - 1925. [Full Text] [PDF] |
||||
![]() |
S. Orimo, T. Uchihara, A. Nakamura, F. Mori, A. Kakita, K. Wakabayashi, and H. Takahashi Axonal {alpha}-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease Brain, March 1, 2008; 131(3): 642 - 650. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |